CRP and diabetes mellitus: In multiple linear regression, increase in MUFA intake was associated with reduction in fasting [ß -1.90 (95% CI -3.08; -0.72)] and 2-h plasma glucose [ß -3.55 (95% CI -6.30; -0.80 (-4.78; -0.62)], adjusted for age, sex, change in leisure physical activity and in saturated fatty acids, family history of diabetes, type of intervention and changes in body weight, waist circumference and CRP levels (Table 3, Model 1 + Change in C-reactive protein).